SUMO-1 (66AT1273.94) Antibody sc-130275 from Santa Cruz Biotechnology, Inc.

Published Figures

Register or Sign In to View Figures.

Molecular medicine reports
September 01 2017

Fig 1: Immunofluorescence analysis of SUMO protein expression in rat hippocampal sections. The expression of SUMO-1 in (A) control group, (B) MCAO group and (C) MCAO + hypothermia group rats. The expression of SUMO-2/3 in (D) control group, (E) MCAO group and (F) MCAO + hypothermia group rats. SUMO, small ubiquitin-related modifier; MCAO, middle cerebral artery occlusion.
Register or Sign In to View Figures.

Molecular medicine reports
September 01 2017

Fig 2: Effects of OGD and hypothermia on SUMO-1 and SUMO-2/3 expression in neurons. (A) After 48 h of OGD, SUMO-1 did not change with time. (B) An immediate and prolonged increase in SUMO-2/3 was observed after OGD. *P<0.05 vs. 0 min conjugated SUMO-2/3. (C) Hypothermia induced a further increase in the conjugation of proteins with SUMO-2/3. *P<0.05 vs. 37°C control group. SUMO, small ubiquitin-related modifier; OGD, oxygen-glucose deprivation.

Be the first to write a review!

Citations:

(1)

Figures:

Supplier Page

Supplier Page from
Santa Cruz Biotechnology, Inc. for
SUMO-1 (66AT1273.94) Antibody

The SUMO-1 (66AT1273.94) Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to small ubiquitin like modifier 1, and SUMO1. This antibody recognizes Homo Sapiens, Human, Mouse, and Rat antigen. The SUMO-1 (66AT1273.94) Antibody has been validated for the following applications: EIA, Immunoassay, Precipitation, ELISA, Immunoprecipitation, and Western Blot.

Description

SUMO-1 (66AT1273.94)

Molecular medicine reports

Molecular medicine reports

SUMO-1 (66AT1273.94) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (1)

Reviews

SUMO-1 (66AT1273.94) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map